Medical Devices Market Research Reports

SEARCH REPORTS

Medical Devices Market Research Reports & Consulting

Medical technology breakthroughs have led to a radical transformation in patient care by enabling a greater focus on clinical outcomes. Minimally invasive or non-invasive medical technologies, for instance, not only shorten recovery time but also lower medical costs. The growth of the markets for telemedicine and drug eluting stents also demonstrate the growing trend in medicine of using cutting-edge technology to enhance clinical outcomes. MarketsandMarkets tracks vital medical devices markets such as orthopedic devices, cardiovascular devices, surgical devices, therapeutic devices, mobility assist devices, self diagnostic devices, and neurostimulators.

Medical devices refer to a broad range of instruments, machines, implants, apparatuses, software, or other similar items that are specifically designed and manufactured for medical purposes. These devices are used in the prevention, diagnosis, treatment, or management of diseases, injuries, or disabilities in humans.

Medical devices can vary in complexity and function. They can be as simple as tongue depressors, thermometers, or bandages, or as advanced as robotic surgical systems, pacemakers, or imaging machines such as MRI (Magnetic Resonance Imaging) scanners.

The primary objective of medical devices is to improve the quality of patient care by providing accurate and reliable diagnostic information, delivering therapies, or assisting in medical procedures. They are often regulated by governmental bodies, such as the Food and Drug Administration (FDA) in the United States, to ensure their safety, effectiveness, and quality.

Medical devices play a crucial role in modern healthcare and are utilized in various settings, including hospitals, clinics, ambulatory care centers, and home healthcare. They are developed through rigorous research, design, testing, and manufacturing processes to meet specific medical requirements and comply with relevant regulations and standards.

Futuristic scope –

The field of medical devices is constantly evolving, and there are several futuristic trends and advancements that hold great potential for improving healthcare in the coming years. Here are some areas with exciting prospects:

Wearable Medical Devices: Wearable devices, such as smartwatches, fitness trackers, and biosensors, are already gaining popularity. In the future, these devices are expected to become more advanced, capable of monitoring a wide range of health parameters, including blood glucose levels, heart rhythm abnormalities, hydration levels, and more. They can provide real-time data and personalized feedback, enabling individuals to actively manage their health and allowing healthcare providers to deliver more precise care.
Telemedicine and Remote Monitoring: Telemedicine and remote patient monitoring have witnessed significant growth, especially during the COVID-19 pandemic. The integration of medical devices with telemedicine platforms will allow patients to receive remote consultations and continuous monitoring of their health conditions. For instance, wearable devices combined with artificial intelligence (AI) algorithms can detect early signs of health deterioration and alert healthcare professionals, enabling proactive interventions and reducing hospitalizations.
Robotics and Minimally Invasive Surgery: Robotic-assisted surgical systems have already revolutionized certain surgical procedures, offering increased precision and control to surgeons. As technology advances, we can expect more sophisticated robotic systems capable of performing complex surgeries with minimal invasiveness. These advancements may lead to shorter recovery times, reduced complications, and improved patient outcomes.
Implantable Devices and Artificial Organs: Implantable medical devices, such as pacemakers and cochlear implants, have been transforming the lives of individuals with chronic conditions. In the future, we may see the development of more advanced implantable devices, including artificial organs and neural interfaces, that can restore or enhance the functioning of specific body systems. These devices could greatly improve the quality of life for people with disabilities or organ failures.
Nanotechnology and Drug Delivery Systems: Nanotechnology has the potential to revolutionize drug delivery and improve targeted therapies. Nanoscale devices or nanoparticles can be engineered to deliver medications precisely to specific cells or tissues, enhancing their effectiveness while minimizing side effects. Additionally, nanosensors could be used for real-time monitoring of various biomarkers within the body, aiding in early disease detection and personalized treatment approaches.
Artificial Intelligence and Machine Learning: AI and machine learning algorithms have the potential to analyze vast amounts of medical data and assist healthcare professionals in diagnosis, treatment planning, and decision-making. These technologies can help identify patterns, predict outcomes, and provide personalized recommendations based on individual patient data. AI-powered medical devices and diagnostic tools can contribute to more accurate and efficient healthcare delivery.

It's important to note that while these futuristic possibilities hold tremendous promise, their successful implementation will require extensive research, rigorous testing, regulatory approvals, and careful consideration of ethical, privacy, and security aspects.

Merger & Acquisition –

Merger and acquisition (M&A) activities in the medical device industry involve the consolidation, integration, or purchase of medical device companies by other companies. These transactions are typically aimed at achieving strategic objectives, such as expanding product portfolios, entering new markets, gaining competitive advantages, or leveraging synergies.

M&A activities in the medical device sector can take various forms, including:

Horizontal M&A: This involves the merger or acquisition of companies operating in the same or similar areas of the medical device industry. It allows companies to expand their market share, eliminate competition, and achieve economies of scale. For example, a company specializing in orthopedic implants may acquire another orthopedic device manufacturer to broaden its product range and strengthen its market position.
Vertical M&A: Vertical integration occurs when a company acquires or merges with a supplier, distributor, or service provider within the medical device supply chain. This strategy aims to streamline operations, control costs, enhance supply chain efficiency, and improve overall business performance. For instance, a medical device manufacturer may acquire a contract manufacturing organization (CMO) to bring manufacturing capabilities in-house and gain greater control over production processes.
Diversification: Companies may engage in M&A activities to diversify their product offerings or enter new market segments. This strategy allows them to reduce reliance on a single product or market and mitigate risks. For example, a company specializing in cardiovascular devices may acquire a company with expertise in neurovascular devices to diversify its product portfolio and expand into a new therapeutic area.
Technology Acquisition: M&A transactions may occur to acquire innovative technologies or intellectual property rights that complement or enhance existing product lines. This strategy enables companies to stay competitive and drive product innovation. For instance, a company focused on diagnostic imaging may acquire a startup with breakthrough imaging technology to strengthen its product capabilities.
Geographic Expansion: M&A activities can facilitate entry into new geographic markets or enhance the global presence of a company. By acquiring companies with established distribution networks or market access in specific regions, companies can expand their reach and capture new customers. This strategy is particularly relevant for companies seeking international growth opportunities.

M&A transactions in the medical device industry are subject to regulatory scrutiny to ensure compliance with antitrust laws and to assess potential impacts on competition and patient welfare. Companies must also carefully consider factors such as financial valuation, integration challenges, cultural alignment, intellectual property rights, and regulatory compliance during the M&A process.

Overall, M&A activities in the medical device sector are driven by strategic objectives and aim to create synergies, drive growth, and enhance competitiveness in an evolving healthcare landscape.

Key segments in Medical Devices:

The medical device industry encompasses various segments that cater to different healthcare needs and specialties. Here are some key segments within the medical device industry:

Diagnostic Devices: Diagnostic devices are used to detect and diagnose medical conditions. This segment includes devices such as imaging systems (X-ray, MRI, CT scanners), ultrasound machines, blood analyzers, molecular diagnostic instruments, and point-of-care testing devices. These devices provide healthcare professionals with critical information for accurate diagnosis and treatment planning.
Therapeutic Devices: Therapeutic devices are designed to deliver treatments or therapies to patients. This segment includes devices such as implantable cardioverter-defibrillators (ICDs), pacemakers, insulin pumps, infusion pumps, nebulizers, ventilators, and dialysis machines. These devices aid in managing chronic conditions, delivering medications, providing respiratory support, and performing life-sustaining functions.
Surgical Devices: Surgical devices are used during surgical procedures to assist surgeons in performing operations. This segment includes devices such as surgical instruments (forceps, scalpels, retractors), electrosurgical devices, surgical lasers, robotic surgical systems, and surgical staplers. These devices enhance precision, minimize invasiveness, and improve surgical outcomes.
Monitoring Devices: Monitoring devices are used to track and measure physiological parameters of patients. This segment includes devices such as vital signs monitors, electrocardiographs (ECG/EKG), blood pressure monitors, glucose meters, pulse oximeters, sleep apnea monitors, and continuous glucose monitoring systems. These devices provide real-time data on a patient's vital signs, enabling healthcare professionals to monitor their condition and make informed decisions.
Rehabilitation and Assistive Devices: Rehabilitation and assistive devices are designed to aid individuals with disabilities or impairments in their daily activities. This segment includes devices such as prosthetics, orthotics, mobility aids (wheelchairs, walkers), hearing aids, visual aids, and assistive technology for communication and mobility. These devices enhance mobility, sensory functions, and overall quality of life for individuals with disabilities.
Implantable Devices: Implantable devices are surgically placed inside the body to restore or enhance specific bodily functions. This segment includes devices such as cardiac implants (pacemakers, defibrillators), neurostimulators, cochlear implants, artificial joints (hips, knees), and intraocular lenses. Implantable devices aim to improve patient health and function by replacing or augmenting damaged or impaired body parts.
Home Healthcare Devices: Home healthcare devices are designed for use in non-hospital settings, allowing patients to receive care and monitoring in the comfort of their homes. This segment includes devices such as home infusion pumps, home dialysis machines, portable oxygen concentrators, sleep apnea machines, and remote monitoring devices. Home healthcare devices promote patient independence, reduce hospital stays, and enable personalized care.

These segments represent a broad overview of the medical device industry, and there are numerous subcategories and specialized devices within each segment. Advances in technology and innovation continue to drive the development of new and improved medical devices across these segments, aiming to enhance patient care and improve healthcare outcomes.

subsegments in Medical Devices:

The medical device industry consists of numerous subsegments that focus on specific areas of healthcare and address specialized needs. Here are some subsegments within the key segments of medical devices:

Diagnostic Devices:

Imaging Devices: X-ray machines, magnetic resonance imaging (MRI) scanners, computed tomography (CT) scanners, ultrasound systems.
In vitro Diagnostic (IVD) Devices: Blood analyzers, molecular diagnostic instruments, immunoassay systems, point-of-care testing devices.
Diagnostic Imaging Contrast Agents: Contrast media used in imaging procedures to enhance visualization.

Therapeutic Devices:

Cardiac Devices: Implantable cardioverter-defibrillators (ICDs), pacemakers, cardiac monitors, cardiac resynchronization therapy devices.
Diabetes Management Devices: Insulin pumps, continuous glucose monitoring systems, blood glucose meters.
Respiratory Devices: Nebulizers, ventilators, continuous positive airway pressure (CPAP) machines.
Renal Devices: Dialysis machines, hemodialysis catheters, peritoneal dialysis systems.

Surgical Devices:

Minimally Invasive Surgical Devices: Laparoscopic instruments, endoscopes, robotic surgical systems.
Surgical Energy Devices: Electrosurgical devices, laser systems, ultrasonic dissectors.
Surgical Instruments: Forceps, scissors, retractors, scalpels, clamps, suturing devices.
Surgical Navigation Systems: Image-guided surgical systems, computer-assisted surgery devices.

Monitoring Devices:

Vital Signs Monitors: Devices for measuring and monitoring parameters such as heart rate, blood pressure, temperature, and respiratory rate.
Electrocardiographs (ECG/EKG): Devices for recording electrical activity of the heart.
Pulse Oximeters: Devices for measuring oxygen saturation levels in the blood.
Holter Monitors: Portable devices for continuous recording of ECG over a period of time.

Rehabilitation and Assistive Devices:

Prosthetics: Artificial limbs and prosthetic devices.
Orthotics: Devices such as braces, splints, and supports for musculoskeletal conditions.
Mobility Aids: Wheelchairs, walkers, crutches, canes.
Hearing Aids: Devices for individuals with hearing impairments.
Visual Aids: Glasses, contact lenses, magnifiers, visual prostheses.

Implantable Devices:

Cardiac Implants: Implantable pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices.
Neurostimulators: Implantable devices for neuromodulation and electrical stimulation for conditions such as chronic pain, Parkinson's disease.
Artificial Joints: Implantable hip, knee, shoulder, and other joint replacements.
Cochlear Implants: Implantable devices for individuals with severe hearing loss.
Intraocular Lenses: Artificial lenses used in cataract surgery to replace the natural lens.

Home Healthcare Devices:

Home Infusion Pumps: Devices for administering medication or fluids at home.
Home Dialysis Machines: Portable devices for performing dialysis at home.
Portable Oxygen Concentrators: Devices for providing oxygen therapy on the go.
Sleep Apnea Devices: Continuous positive airway pressure (CPAP) machines, oral appliances.
Remote Monitoring Devices: Devices for remote patient monitoring and telehealth services.

These subsegments represent specific areas of focus within each key segment of medical devices, catering to specialized medical needs and conditions. They reflect the diverse range of medical devices available to address various healthcare challenges and improve patient outcomes.

Medical Devices Ecosystem:

Manufacturers: Medical device manufacturers are responsible for designing, developing, and manufacturing medical devices. They conduct research, ensure regulatory compliance, and manage production processes to bring innovative and safe devices to the market.
Regulatory Authorities: Regulatory authorities, such as the FDA in the United States and the European Medicines Agency (EMA) in Europe, play a crucial role in overseeing the safety, efficacy, and quality of medical devices. They establish guidelines, review applications, and issue approvals or clearances to ensure devices meet regulatory standards.
Healthcare Providers: Healthcare providers, including hospitals, clinics, and healthcare professionals, utilize medical devices to diagnose, treat, and monitor patients. They rely on devices for accurate diagnostics, effective therapies, and improved patient care.
Distributors: Distributors act as intermediaries between manufacturers and healthcare providers, facilitating the supply chain and ensuring devices reach end-users. They handle logistics, inventory management, sales, and after-sales support.
Research and Development: Research and development (R&D) institutions, both within companies and academic settings, contribute to the advancement of medical devices. They conduct research, develop prototypes, and explore new technologies to drive innovation and improve medical device functionality.
Testing and Certification Organizations: Testing and certification organizations play a vital role in evaluating the safety, performance, and compliance of medical devices. They conduct testing, inspections, and audits to ensure devices meet quality standards and regulatory requirements.
Healthcare Professionals and Users: Healthcare professionals, including doctors, nurses, and technicians, play a critical role in the proper use and application of medical devices. They receive training, interpret device outputs, and provide care based on device-generated information. Patients and end-users also interact with medical devices for self-monitoring, home healthcare, and managing their health conditions.
Support Services: Support services, such as maintenance and repair providers, calibration laboratories, and technical support teams, assist in device upkeep, troubleshooting, and ensuring devices are functioning optimally.
Data Management and Analytics: With the rise of digital health, data management and analytics have become crucial in the medical devices ecosystem. Software platforms, cloud services, and analytics companies handle data collection, storage, analysis, and integration, enabling insights for personalized care, population health management, and clinical decision support.
Patients and Caregivers: Patients and caregivers are essential stakeholders in the medical devices ecosystem. They rely on devices to monitor health conditions, manage treatments, and enhance quality of life. Their feedback, adherence to device usage, and experience provide valuable insights for device improvement and innovation.

The medical devices ecosystem encompasses a wide range of stakeholders, each playing a distinct role in the development, deployment, and utilization of medical devices to improve healthcare outcomes and patient well-being.

Top players:

The medical device industry is home to several top players that have established themselves as leaders in the global market. Here are some of the prominent companies in the medical device sector:

Medtronic: Medtronic is a multinational medical device company based in Ireland. It offers a wide range of products across various therapeutic areas, including cardiac and vascular, minimally invasive therapies, restorative therapies, and diabetes management. Medtronic is known for its innovative devices such as pacemakers, defibrillators, insulin pumps, and surgical instruments.
Johnson & Johnson: Johnson & Johnson is a diversified healthcare company with a significant presence in the medical device industry. Its subsidiary, Ethicon, is a leader in surgical devices, including sutures, staplers, and energy devices. Johnson & Johnson's medical device portfolio also includes orthopedic implants, cardiovascular devices, diabetes care products, and vision care solutions.
Abbott Laboratories: Abbott is a global healthcare company that develops and manufactures a wide range of medical devices and diagnostics. Its product offerings include cardiovascular devices (e.g., stents, heart valves), diabetes care products (e.g., glucose monitoring systems, insulin pumps), diagnostic instruments, molecular diagnostics, and point-of-care testing devices.
Siemens Healthineers: Siemens Healthineers is a leading medical technology company focused on diagnostic imaging systems, laboratory diagnostics, and advanced healthcare IT solutions. The company's products range from X-ray, CT, and MRI systems to in vitro diagnostics equipment and clinical laboratory analyzers.
GE Healthcare: GE Healthcare, a division of General Electric, provides a comprehensive portfolio of medical devices, including diagnostic imaging systems, ultrasound machines, patient monitoring systems, and life support equipment. The company also offers healthcare IT solutions and services.
Stryker Corporation: Stryker is a global medical technology company specializing in orthopedics, medical and surgical equipment, and neurotechnology and spine products. It offers a wide range of innovative devices for joint replacement, trauma surgery, surgical navigation, and neurovascular interventions.
Becton, Dickinson and Company (BD): BD is a leading global medical technology company that develops and manufactures a diverse range of medical devices and solutions. The company's product offerings include injection and infusion systems, diagnostic systems, surgical instruments, and advanced bioprocessing technologies.
Boston Scientific Corporation: Boston Scientific is a renowned medical device company focused on areas such as cardiovascular interventions, rhythm management, urology and pelvic health, endoscopy, and neuromodulation. It develops and markets devices for procedures like coronary stenting, pacemakers, catheters, and endoscopic tools.
Zimmer Biomet Holdings: Zimmer Biomet is a global leader in musculoskeletal healthcare, specializing in orthopedic implants, surgical instruments, and advanced technologies for joint reconstruction, sports medicine, spine surgery, and dental applications.
Philips Healthcare: Philips Healthcare offers a wide range of medical devices and solutions, including imaging systems (such as CT and MRI), patient monitoring systems, respiratory care devices, and home healthcare solutions. The company focuses on integrating technology and data to improve patient outcomes and healthcare efficiency.

These companies have established strong market positions through their product portfolios, technological innovation, global presence, and commitment to advancing healthcare. However, it's important to note that the medical device industry is highly competitive, and there are several other notable players contributing to the advancement of medical technology.

High grown opportunities:

The medical device industry offers numerous high-growth opportunities driven by various factors such as technological advancements, increasing healthcare needs, and evolving market dynamics. Here are some key areas that present significant growth opportunities in the medical device sector:

Digital Health and Connected Devices: The integration of digital technologies and connectivity in medical devices is transforming healthcare delivery. Opportunities exist in the development of wearable devices, remote patient monitoring systems, mobile health applications, telemedicine platforms, and digital therapeutics. These technologies enhance patient engagement, enable real-time monitoring, and facilitate personalized healthcare delivery.
Minimally Invasive and Robotic-Assisted Surgery: Minimally invasive surgical techniques and robotic-assisted surgery have gained significant popularity due to their potential to reduce invasiveness, shorten recovery times, and improve surgical outcomes. The demand for advanced surgical instruments, robotic systems, and imaging technologies for minimally invasive procedures is expected to grow as more healthcare providers adopt these techniques.
Personalized Medicine and Point-of-Care Diagnostics: Advances in genomics, molecular diagnostics, and personalized medicine have created opportunities for the development of innovative diagnostic devices. Point-of-care testing devices, genetic testing platforms, and companion diagnostics are witnessing growth as they enable targeted treatments, improve disease management, and enhance patient outcomes.
Artificial Intelligence and Machine Learning: Artificial intelligence (AI) and machine learning (ML) technologies have the potential to revolutionize medical devices by improving diagnostic accuracy, predicting patient outcomes, and enabling real-time data analysis. AI-powered imaging systems, predictive analytics tools, and decision support systems are emerging as growth areas within the medical device industry.
Remote Monitoring and Home Healthcare: The shift towards patient-centered care and the aging population have fueled the demand for remote monitoring devices and home healthcare solutions. Remote patient monitoring systems, wearable health trackers, and home-based medical devices are expected to experience significant growth as they enable continuous monitoring, early intervention, and personalized care outside traditional healthcare settings.
Advanced Implantable Devices: The market for implantable medical devices, such as cardiac implants, neurostimulators, and orthopedic implants, continues to grow as the aging population increases and the demand for improved quality of life rises. Advancements in materials, biocompatibility, and design are driving the development of next-generation implantable devices with enhanced functionality and durability.
Emerging Markets: Emerging markets, particularly in Asia, Latin America, and Africa, offer substantial growth opportunities for medical device companies. Rising healthcare expenditures, increasing access to healthcare services, and expanding middle-class populations are driving demand for medical devices in these regions. Companies that can effectively navigate regulatory landscapes, adapt to local needs, and provide affordable solutions have the potential for significant growth in emerging markets.

It's important to note that the medical device industry is subject to regulatory requirements and challenges related to reimbursement, intellectual property, and market competition. Companies that can navigate these complexities while addressing evolving healthcare needs stand to benefit from the high-growth opportunities within the medical device sector.

Challenges in Medical Devices Industry:

The medical device industry faces several challenges that impact its growth, innovation, and market dynamics. Here are some key challenges in the medical device industry:

Regulatory Compliance: Medical devices are subject to strict regulations and standards to ensure safety, efficacy, and quality. Obtaining regulatory approvals, navigating complex compliance requirements, and managing post-market surveillance can be time-consuming and costly for medical device companies.
Reimbursement and Pricing Pressures: Reimbursement policies and pricing pressures pose challenges for medical device manufacturers. Negotiating reimbursement contracts with healthcare payers and demonstrating cost-effectiveness and clinical value are essential to gain market access and sustain profitability.
Technological Advancements and Innovation: The medical device industry is highly competitive, and staying at the forefront of technological advancements is critical. Companies face the challenge of continuously innovating and developing new devices with enhanced features, improved outcomes, and cost-effectiveness.
Intellectual Property Protection: Protecting intellectual property (IP) rights is crucial for medical device companies. The industry is susceptible to patent disputes, infringement issues, and challenges in safeguarding proprietary technologies. Ensuring strong IP protection and defending against potential legal threats are ongoing challenges.
Market Access and Global Expansion: Expanding into new markets, especially international markets, can be challenging due to variations in regulatory requirements, cultural differences, and market dynamics. Establishing distribution networks, complying with local regulations, and understanding market needs are critical for successful market access and expansion.
Cost and Time to Market: Developing and commercializing medical devices involve significant investments in research and development, clinical trials, and manufacturing. Long development timelines, cost overruns, and delays in obtaining regulatory approvals can impact companies' ability to bring products to market in a timely and cost-effective manner.
Healthcare System Adoption: Healthcare systems and providers may be slow to adopt new technologies and devices due to factors such as budget constraints, resistance to change, and concerns about reimbursement. Demonstrating clinical evidence, cost-effectiveness, and addressing barriers to adoption are essential for widespread acceptance and adoption of medical devices.
Data Security and Privacy: With the increasing use of connected devices and digital health technologies, data security and privacy have become critical concerns. Protecting patient data, ensuring cybersecurity measures, and complying with data privacy regulations present ongoing challenges for medical device companies.
Supply Chain Disruptions: Disruptions in the global supply chain, such as raw material shortages, transportation issues, and geopolitical events, can impact the production and availability of medical devices. Ensuring supply chain resilience and mitigating risks are vital to maintain uninterrupted device availability.
Healthcare Cost Containment: Healthcare systems globally are under pressure to contain costs. Medical device companies need to address the cost-effectiveness of their devices, demonstrate economic value, and work collaboratively with healthcare providers to meet cost containment objectives.

Navigating these challenges requires strategic planning, collaboration with stakeholders, investment in research and development, and a deep understanding of market dynamics. Companies that can effectively address these challenges have a better chance of succeeding in the competitive medical device industry.

High CAGR geography:

The Compound Annual Growth Rate (CAGR) of the medical device industry can vary across different geographies due to factors such as population demographics, healthcare infrastructure, regulatory environments, and economic growth. While it is difficult to predict the precise CAGR for specific geographies, there are regions that have shown potential for high growth in the medical device sector. Here are a few geographies that have been identified as having a high CAGR for medical devices:

Asia-Pacific: The Asia-Pacific region has witnessed significant growth in the medical device market. Countries like China, India, and Japan have large populations with increasing healthcare needs. Rising disposable incomes, improving healthcare infrastructure, and government initiatives to enhance healthcare access have contributed to the growth of the medical device sector in this region.
Latin America: Latin America is another geography with a high growth potential for medical devices. Countries such as Brazil, Mexico, and Argentina have expanding middle-class populations and increasing healthcare expenditures. The demand for medical devices in areas such as diagnostic imaging, surgical instruments, and cardiovascular devices is expected to grow in this region.
Middle East and Africa: The Middle East and Africa region is experiencing rapid growth in healthcare infrastructure and spending. Countries like Saudi Arabia, United Arab Emirates, South Africa, and Kenya are investing in modernizing healthcare facilities and expanding access to medical services. This creates opportunities for medical device companies, particularly in areas such as diagnostic imaging, patient monitoring, and surgical equipment.
North America: Despite being a mature market, North America, especially the United States, continues to offer growth opportunities in the medical device sector. Technological advancements, increasing chronic disease prevalence, and a focus on value-based healthcare are driving the demand for innovative medical devices and technologies in this region.
Europe: Europe remains a significant market for medical devices, with countries like Germany, France, and the United Kingdom being major contributors. The region's aging population, favorable reimbursement policies, and a focus on healthcare modernization create opportunities for medical device companies, particularly in areas such as implantable devices, diagnostic imaging, and in vitro diagnostics.

see less

Market Reports

Veterinary PoC Diagnostics Market by Product (Imaging Systems, Analyzers, Reagents), Technology (Immuno & Molecular Diagnostics), Application (Pathology, Bacteriology, Gynecology), Animal (Cat, Dog, Horse, Cattle), End User & Region - Global Forecast to 2025

The global veterinary PoC diagnostics market growth is primed to transition from $1.4 billion in 2019 to $2.4 billion by 2025, showcasing a strong CAGR of 8.9%. Key drivers include the rising prevalence of zoonotic diseases in animals and the need for rapid diagnostics, though high costs of imaging equipment pose a challenge.
- Published: May 2020
- Price: $ 4950
- TOC Available:
Centesis Catheters Market Size by Type (Small and Large bore), Procedure (Paracentesis, Thoracentesis, Amniocentesis), Application (Diagnosis, Therapeutics and Palliative care), End user (Hospitals, Ambulatory surgery centers), Region - Global Forecasts to 2025

The size of centesis catheters market in terms of revenue was estimated to be worth USD 426 million in 2019 and is poised to reach USD 633 million by 2025, growing at a CAGR of 6.8% from 2019 to 2025. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: May 2020
- Price: $ 4950
- TOC Available:
Veterinary Monitoring Equipment Market by Type (Vital Signs Monitor, Anesthesia Monitor, ECG Monitor), Target Area (Respiratory diseases, Weight Monitoring), Animal Type (Dogs, Cats, Equines), End User (Veterinary Clinic), Region - Global Forecast to 2025

The Veterinary Monitoring Equipment Market is expected to grow from USD 326 million in 2019 to USD 570 million by 2025, at a CAGR of 9.8% during the forecast period. Prominent players in the veterinary monitoring equipment market include Smiths Group plc. (UK), DRE Veterinary (US), Digicare Biomedical Technology (US), Midmark Corporation (US), Medtronic plc. (Ireland), Bionet America, Inc. (Korea), SonoScape Medical Corporation (China), Hallowell EMC (US), MinXray, Inc. (US), Hallmarq Veterinary Imaging Ltd. (UK), Esaote S.p.A (Italy), Agfa-Gevaert N.V. (Belgium), Nonin Medical, Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Covetrus, Inc. (US), Vetland Medical Sales & Services LLC (US), Masimo Corporation (US), Burtons Medical Equipment Ltd. (UK), Vetronic Services (UK), and IMV Technologies (France).
- Published: May 2020
- Price: $ 4950
- TOC Available:
Medical Wearables Market by Device (Vital Signs Monitoring, Blood Pressure Monitor, Glucose Monitor, ECG Monitor, Pulse Oximeter), Product (Smartwatch, Patches, Wristbands), End User (Hospitals, Nursing Homes, Ambulatory) & Region - Global Forecast to 2025

The global medical wearables market in terms of revenue was estimated to be worth $7.4 billion in 2020 and is poised to reach $19.5 billion by 2025, growing at a CAGR of 21.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: May 2020
- Price: $ 4950
- TOC Available:
Biofilms Treatment Market by Products (Debridement Equipment, Gauze, Dressing, Gel, Ointment), Wound Type (Traumatic, Surgical, Open, Diabetic Foot, Venous Leg Ulcer & Burns), End User (Hospital, ASCs, Wound Care Centers, Homecare) & Region - Global Forecast to 2025

The global biofilms treatment market growth is primed to transition from USD 1.6 billion in 2020 to USD 2.4 billion by 2025, showcasing a strong CAGR of 7.9%. Market growth is driven by the rising prevalence of chronic, surgical, and traumatic wounds and the increasing incidence of burn injuries.
- Published: May 2020
- Price: $ 4950
- TOC Available:
COVID 19 Impact on IVD (In Vitro Diagnostics) Market by Technology (PCR, NGS, ELISA, Rapid Test, Hematology, Hemostasis, Clinical Chemistry, Microbiology Testing, Urinalysis), End-user and Region - Global Forecast to 2025

The COVID 19 Impact on IVD (In Vitro Diagnostics) Market is expected to grow from USD 61.7 billion in 2020 to USD 77.9 billion by 2025, at a CAGR of 4.8% during the forecast period. As of 2019, some of the prominent players in the in-vitro diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Biomerieux (France), and QIAGEN (Germany), among others.
- Published: May 2020
- Price: $ 4950
- TOC Available:
COVID-19 Impact on Critical Care Device Market by Device (High-Impact Products (Ventilators, Patient Monitors, Infusion Pumps, Hyperbaric Oxygen Therapy Devices and Sleep Apnea Devices) and Low-Impact Products (Anesthesia Machines, Defibrillators and Blood Warmers)) and Region - Global Forecast to 2021

The global critical care devices market size is expected to reach USD 27.29 billion by 2021 from an estimated value of USD 37.97 billion in 2020. The critical care devices market is expected to witness a growth of 44.1% from 2019 to 2020. The prominent players in the global critical care devices market are Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Fresenius Kabi (Germany), Medtronic plc (Ireland), Moog Inc. (US), Smiths Medical (US), and Philips Healthcare (Netherlands), among others
- Published: May 2020
- Price: $ 4950
- TOC Available:
COVID-19 impact on Medical Supplies Market by Type (Intubations, Personal Protective Equipment, Infusion, Radiology, Wound Care Supplies), End User (Hospitals, Clinics) - Global Forecast to 2021

The COVID-19 impact on Medical Supplies Market is expected to grow from USD ~78 billion in 2019 to USD ~100 billion by 2021, at a CAGR of 13.4% during the forecast period. The prominent players in the medical supplies market are Medtronic plc (Ireland), Cardinal Health, Inc. (US), Becton, Dickson and Company (US), Johnson & Johnson (US), and B. Braun Melsungen AG (Germany), Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), STERIS Corporation (US), Getinge Group (Sweden), Advanced Sterilization Products (US), 3M Company (US), Smith & Nephew (U.K.), Mölnlycke Health Care AB (Sweden), among others.
- Published: April 2020
- Price: $ 4950
- TOC Available:
Wound Debridement Market by Product (Enzymatic, Autolytic (Gels, Ointments), Mechanical (Medical Gauzes), Surgical, Ultrasonic), Wound Type (Diabetic Foot Ulcers, Venous Leg, Pressure Ulcers, Burns), End User (Hospitals, Clinics) & Region - Global Forecast to 2025

The global wound debridement market in terms of revenue was estimated to be worth $822 million in 2020 and is poised to reach $1,162 million by 2025, growing at a CAGR of 7.2% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: April 2020
- Price: $ 4950
- TOC Available:
Negative Pressure Wound Therapy Market by Type (Conventional, Disposable NPWT, Accessories, Rental & Sales Volume), Wound Type (Surgical, Traumatic, Diabetic Foot, Pressure, Venous Leg Ulcers), End User (Hospital, Homecare) & Region - Global Forecast to 2025

The global negative pressure wound therapy market growth is primed to transition from $2.4 billion in 2020 to $3.2 billion by 2025, showcasing a strong CAGR of 6.1%. Key drivers of this market include the rising prevalence of chronic and surgical wounds, government initiatives to prevent surgical site infections (SSIs), and the increasing prevalence of diabetes.
- Published: April 2020
- Price: $ 4950
- TOC Available:
Autoimmune Disease Diagnosis Market by Product (Consumables, Assay Kits, Instruments), Test Type (Inflammatory Markers, Routine Laboratory Tests), Disease (RA, SLE, Thyroiditis, Scleroderma), End User (Hospitals, Clinical Labs) & Region – Global Forecast to 2025

The global autoimmune disease diagnosis market growth is primed to transition from USD 4.1 billion in 2020 to USD 6.3 billion by 2025, showcasing a strong CAGR of 8.9%. This industry is experiencing significant growth due to the high incidence of autoimmune diseases, increasing awareness about autoimmune diseases, and the growth in research on autoimmune diseases.
- Published: April 2020
- Price: $ 4950
- TOC Available:
Dental Imaging Market by Product (CBCT, Intraoral X ray, Intraoral Cameras, Intraoral Scanners), Application (Oral and Maxillofacial Surgery, Implantology) & End User (Dental Hospitals & Clinics, Dental Diagnostic Centers) & Region - Global Forecast to 2025

The global dental imaging market growth is primed to transition from $2.6 billion in 2020 to $4.1 billion by 2025, showcasing a strong CAGR of 9.0%. The rising demand for cosmetic dentistry, the growing affordability of imaging systems, and the need for rapid and accurate diagnosis are the other major factors driving the growth of this market.
- Published: March 2020
- Price: $ 4950
- TOC Available:
Resuscitation Devices Market by Product (Defibrillator, Endotracheal & Tracheostomy Tube, Masks, Airways, Laryngoscopes, Resuscitators, Ventilators), Patient Type (Neonatal, Adult), End User (Hospital, Ambulance, ICU), Volume & Region - Global Forecasts to 2025

The global resuscitation devices market in terms of revenue was estimated to be worth $6.9 billion in 2020 and is poised to reach $8.7 billion by 2025, growing at a CAGR of 4.7% from 2020 to 2025. Prominent players in this market includes Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), ZOLL Medical Corporation (US), ResMed Inc. (US), Physio-Control (acquired by Stryker Corporation) (US), Drägerwerk AG & Co. KGaA (Germany), Smiths Medical (US), Ambu (Denmark), Cardinal Health (US), Mindray Medical (China), Nihon Kohden (Japan), Teleflex (US), Salter Labs (US), GE Healthcare (US), Roper Technologies (US), Vyaire Medical (US), Intersurgical (UK), 3M (US), Flexicare (UK), and KARL STORZ (Germany).
- Published: March 2020
- Price: $ 4950
- TOC Available:
Catheters Market by Type (Cardiovascular (IVUS Catheter, Guiding Catheter, Balloon Catheter), Urology catheter (Dialysis, Foley, Intermittent Catheter), Intravenous Catheter (Central Venous Catheter)), & End User (Hospital) - Global Forecast to 2025

The global catheters market growth is primed to transition from $15.9 billion in 2020 to $24.2 billion by 2025, showcasing a strong CAGR of 8.7%. The demand for catheters is majorly driven by the growth in the target patient population and the rising focus on minimally invasive surgical procedures over conventional surgery.
- Published: February 2020
- Price: $ 4950
- TOC Available:
Fiducial Markers Market by Product (Metal Based Markers (Gold, Gold Combination) Polymer Markers), Cancer Type (Prostate, Lung, Breast), Modality (CT, CBCT, MRI, Ultrasound), End User (Hospitals, Outpatient Facilities) & Region - Global Forecast to 2025

The global fiducial markers market growth is primed to transition from $95 million in 2019 to $123 million by 2025, showcasing a strong CAGR of 4.5%. Increasing investments, funds, and grants by public-private organizations for cancer research, technological advancements in the market, and the rising cancer burden globally will fuel market growth over the forecast period.
- Published: February 2020
- Price: $ 4950
- TOC Available:
Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region - Global Forecasts to 2024

The global cardiac mapping market in terms of revenue was estimated to be worth $1.4 billion in 2019 and is poised to reach $2.1 billion by 2024, growing at a CAGR of 8.7% from 2019 to 2024. The major vendors in the market include Biosense Webster (US), Abbott (US), and Boston Scientific Corporation (US). These leading players offer a strong suit of products for cardiac mapping and have a broad geographic presence. The other players in this market include Medtronic (Ireland), MicroPort Scientific Corporation (China), EP Solutions SA (Switzerland), Acutus Medical (US), Koninklijke Philips N.V. (Royal Philips) (Netherlands), Lepu Medical (China), BIOTRONIK (Germany), AngioDynamics (US), BioSig Technologies (US), APN Health (US), CoreMap (US), Kardium (Canada), Catheter Precision (US), and Epmap-System (Germany).
- Published: January 2020
- Price: $ 4950
- TOC Available:
Patient Blood Management Market by Product (Instrument (Centrifuge, Transfusion Device, Apheresis, PCR, NGS, Storage Device), Accessories (Syringes, Vials), Reagents, Software)), Component, End User (Blood Bank, Hospital) - Global Forecast to 2024

The global patient blood management market size is expected to grow USD 15.3 billion by 2024, at a CAGR of 7.4% during the forecasting period. The major players in the market include Haemonetics Corporation (US), Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Immucor, Inc. (US), B. Braun Melsungen AG (Ireland), Macopharma (US), bioMérieux SA (France), Asahi Kasei Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), Grifols, S.A. (Spain), F. Hoffmann-La Roche LTD (Switzerland), LivaNova PLC (UK), Danaher Corporation (US), Mediware Information Systems (US), Kawasumi Laboratories, Inc. (Japan), Haier Biomedical (China), Diatron (Hungary), and BAG Diagnostics GmbH (Germany), among others.
- Published: December 2019
- Price: $ 4950
- TOC Available:
Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User and Region - Global Forecasts to 2024

The neurodiagnostics market is projected to reach USD 8.4 billion by 2024, at a CAGR of 7.3%. Some of the prominent players in this market includes GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), Nihon Kohden Corporation (Japan), ANT Neuro (Netherlands), Fonar Corporation (US), Fujirebio (Japan), DRG Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems Co., Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US).
- Published: December 2019
- Price: $ 4950
- TOC Available:
Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) - Global Forecasts to 2024

The Lymphedema Diagnostics Market is expected to grow from USD 24 million in 2019 to USD 35 million by 2024, at a CAGR of 7.4% during the forecast period. The major players operating in the lymphedema diagnostics market are GE Healthcare (US), Philips (Netherlands), and Siemens Healthineers (Germany). Other prominent players in this market include Canon, Inc. (Japan), Shimadzu Corporation (Japan), Stryker Corporation (US), Fluoptics (France), United Imaging Healthcare Co., Ltd. (China), Hitachi, Ltd. (Japan), Esaote, SpA (Italy), Neusoft Corporation (China), Mindray Medical International, Ltd. (China), Mitaka USA, Inc. (US), Curadel, LLC (US), and ImpediMed Ltd. (Australia).
- Published: October 2019
- Price: $ 4950
- TOC Available:
Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD) - Global Forecast to 2024

The electronic drug delivery system market is expected to grow from USD 7.8 billion in 2019 to USD 11.9 billion by 2024, at a compound annual growth rate (CAGR) of 8.7%. during the forecast period.The prominent players in the electronic drug delivery systems market are Insulet Corporation (US), Bayer AG (Germany), Medtronic (Ireland), Novo Nordisk A/S (Denmark), Companion Medical (US), F.Hoffmann-La Roche Ltd (Switzerland), United Therapeutics Corporation (US), AstraZeneca (UK), Tandem Diabetes Care (US), Merck Group (Germany), and Amgen (US).
- Published: October 2019
- Price: $ 4950
- TOC Available:
Tracheostomy Products Market by Product (Tracheostomy Tube (Double Lumen, Cuffed, Fenestrated), Accessories), Technique (Ciaglia Blue Rhino, Translaryngeal, Percutwist, Shachner/Rapitrac, Translaryngeal/Fantoni), End-User & Region - Global Forecasts to 2024

The tracheostomy products market is projected to reach USD 220 million by 2024, at a CAGR of 4.2%. The major players operating in this market are Medtronic plc (Ireland), Smiths Group plc (UK), TRACOE Medical GmbH (Germany), Teleflex Incorporated (US), and Fisher & Paykel Healthcare Ltd. (New Zealand). Other prominent players operating in this market include ConvaTec Group (US), Cook Group (US), Troge Medical GmbH (Germany), Well Lead Medical Co., Ltd. (US), Fuji Systems Corporation (Japan), Andreas Fahl Medizintechnik-Vertrieb GmbH (Germany), Xinxiang Huaxi Sanitary Materials Co., Ltd. (China), Medis Medical (Tianjin) Co. Ltd. (China), Boston Medical (US), and Pulmodyne (US).
- Published: September 2019
- Price: $ 4950
- TOC Available:
Neurosurgery Devices Market by Product (Neuromodulation(Spinal Cord Stimulation, Deep Brain Stimulation) Neuroendoscopy), Application (Chronic Pain, Depression, Parkinsons, Ischemia, Transnasal Neuroendoscopy), Region - Global Forecast to 2024

The Neurosurgery Devices Market is expected to grow from USD 7.3 billion in 2019 to USD 13.5 billion by 2024, at a CAGR of 13.0% during the forecast period. Major players operating in the neurosurgery devices market include B. Braun Melsungen (Germany), Medtronic (US), Boston Scientific Corporation (US), Nevro Corporation (US), KARL STORZ (Germany), Abbott (US), Ackermann Instrumente (Germany), Hawk (China), Machida Endoscope (Japan), and adeor Medical (Germany).
- Published: September 2019
- Price: $ 4950
- TOC Available:
Autotransfusion Systems Market by Type (Autotransfusion Products & Accessories) and Application (Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Other Procedures) - Global Forecast to 2024

The Autotransfusion Systems Market is expected to grow from USD 395 million in 2019 to USD 505 million by 2024, at a CAGR of 5.0% during the forecast period. Becton, Dickinson and Company (US), Zimmer Biomet Holdings, Inc. (US), Teleflex Incorporated (US), and Haemonetics Corporation (US) are some of the major players operating in the North American market.
- Published: August 2019
- Price: $ 4950
- TOC Available:
Microsurgical Instruments Market by Type (Operating Microscopes, Micro Sutures (Non-Absorbable & Absorbable), Forceps, Needle Holder), Microsurgery (Plastic, Ophthal, ENT, Orthopedic, GYN), End User (Hospitals, ASCs, Academia) - Global Forecast to 2024

The Microsurgical Instruments Market is expected to grow from USD 1.7 billion in 2019 to USD 2.2 billion by 2024, at a CAGR of 1.7% during the forecast period. B. Braun Melsungen AG (Germany), ZEISS International (Germany), Danaher Corporation (US), Olympus Corporation (Japan), Novartis AG (Switzerland), Karl Kaps GmbH & Co. KG (Germany), Scanlan International (US), Topcon Corporation (Japan), Global Surgical Corporation (US), Haag-Streit Surgical (Germany), Accurate Surgical & Scientific Instruments (US), and Stille (Sweden) are some of the key players in the microsurgical instruments market.
- Published: August 2019
- Price: $ 4950
- TOC Available:
Patient Lifting Equipment Market by Product (Ceiling/Overhead Lift, Stair Lift, Mobile/Floor Lift, Sit to Stand Lift, Bath & Pool Lift, Lifting Slings, Lifting Accessories), End User (Hospital, Home Care, Elderly Care Facility) - global forecast to 2024

The Patient Lifting Equipment Market is expected to grow from USD 3.0 billion in 2019 to USD 5.4 billion by 2024 at a CAGR of 12.7% during the forecast period. Increasing global geriatric & bariatric populations, the high risk of injuries to caregivers during the manual handling of patients, and the implementation of regulations ensuring the safety of healthcare personnel during manual lifting are the key factors driving the market growth. The major companies in the global patient lifting equipment market include Arjo (Sweden), Hill-Rom (US), Invacare (US), Handicare (Sweden), and Guldmann (US).
- Published: July 2019
- Price: $ 4950
- TOC Available:
Metal Implants and Medical Alloys Market by Type (Titanium, Stainless Steel, Cobalt Chrome), Application (Orthopedic, Dental, Spinal Fusion, Craniofacial, Pacemaker, Stent, Defibrillator, Hip, Knee, & Shoulder Reconstruction) - Global Forecast to 2024

The metal implants and medical alloys market is projected to reach USD 17.6 billion by 2024 from USD 11.2 billion in 2019, at a CAGR of 9.4%. Factors such as the growing number of trauma/accidental cases, the growing ageing population, and the rising prevalence of chronic disorders are driving the growth of the metal implants and medical alloys market. The prominent players in the metal implants and medical alloys market are Carpenter Technology Corporation (US), Royal DSM (Netherlands), Johnson Matthey Plc (UK), ATI Specialty Alloys & Components (US), Ametek Specialty Products (US), Aperam S.A. (Luxembourg), QuesTek Innovations LLC (US), and Fort Wayne Metals (US).
- Published: June 2019
- Price: $ 4950
- TOC Available:
Depth of Anesthesia Monitoring Market by Product (Devices, Consumables), Device (Module, Standalone), Mode of Purchase (Group Purchasing Organization, Direct Purchase), End User (Hospitals, Ambulatory Surgery Center, Clinic) - US Forecast to 2024

The depth of anesthesia monitoring market size is projected to reach USD 170 million by 2024, at a CAGR of 3.2%. The growth of this market is primarily driven by the growing patient pool in hospitals in the US and the increasing number of surgeries. However, the high installation and maintenance costs of depth of anesthesia monitoring devices are expected to restrain the growth of this market in the coming years. The prominent players operating in this market include Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Medtronic Public Limited Company (Ireland), GE Healthcare (US), Mennen Medical Ltd. (Israel), Masimo Corporation (US), and Philips Healthcare (Netherlands).
- Published: June 2019
- Price: $ 4950
- TOC Available:
Airway Stent/Lung Stent Market by Type (Tracheal, Bronchial, Laryngeal Stent), Product (Non-Expandable, Self-Expandable Stents), Material (Metal (Nitinol, Stainless Steel), Silicone, Hybrid), End User (Hospitals, ASCs) - Global Forecasts to 2024

The lung stent market is projected to reach USD 120 million by 2024, at a CAGR of 6.7%. The major players operating in the lung stent market include Boston Scientific Corporation (US), Taewoong Medical Co., Ltd. (South Korea), Micro-Tech (Nanjing) Co., Ltd. (China), Novatech SA (France), Boston Medical Products, Inc. (US), E. Benson Hood Laboratories, Inc. (US), Merit Medical Systems, Inc. (US), Cook Group (US), EFER ENDOSCOPY (France), ENDO-FLEX GmbH (Germany), Standard Sci. Tech Inc. (South Korea), and Stening SRL (Argentina), among others.
- Published: June 2019
- Price: $ 4950
- TOC Available:
China Hemodialysis and Peritoneal Dialysis Market by Product & Services (HD, PD, Machine, Dialyzer, Concentrate, Dialysate, Catheter, Service), Modality (CAPD, APD, Nocturnal), End User (Hospital, Independent Center, Home Dialysis) - Forecast to 2024

The China hemodialysis and peritoneal dialysis market is projected to grow from an estimated USD 5.0 billion in 2019 to USD 7.4 billion by 2024, at a CAGR of 8.5% during the forecast period. Market growth is largely driven by factors such as increasing number of ESRD patients, growing prevalence of diabetes & hypertension (major causes of kidney failure), and preference for dialysis treatments over kidney transplants due to lack of donors. Furthermore, rise in the number of dialysis centers across China coupled with the increasing interest of market players to expand their network in the country through the acquisition of dialysis facilities is adding growth opportunities to China hemodialysis and peritoneal dialysis market. Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US) and Shandong Weigao Group Medical Polymer Company Limited (China) dominated the China hemodialysis and peritoneal dialysis market. Other players in this market include B. Braun Melsungen AG (Germany), Nikkiso Co. Ltd. (Japan), DaVita Healthcare Partners, Inc (US), Asahi Kasei Medical Co., Ltd (Japan), Bain Medical Equipment Co., Ltd. (China), Huaren Pharmaceutical (China), and Jiangsu Lengthen Life Science and Technology Co. Ltd (China).
- Published: June 2019
- Price: $ 4950
- TOC Available:
Bed Monitoring System & Baby Monitoring System Market by Type (Baby Monitor (Sensor & Wearable), Pressure Ulcer, Elderly Monitor (Fall Prevention), Sleep Monitor), End User (Home Care, Nursing Home & Assisted Living Facilities) - Global Forecast to 2024

The market for bed monitoring system & baby monitoring system is projected to reach USD 1.9 billion by 2024, at a CAGR of 7.9% during the forecast period. The report covered sensor pads or smart mattresses embedded with the sensors for bedsore monitoring, baby monitoring, elderly monitoring, and sleep monitoring. The growth of this market is driven primarily by factors such as growing investments in healthcare infrastructural development, increasing elderly population, rising adoption of unobtrusive monitoring solutions, increasing focus on reducing the treatment cost of pressure ulcer & fall injuries and increasing online availability & purchase of products. However, lack of awareness and acceptance of the products in developing countries is expected to restrain the growth of this market during the forecast period. The prominent players in this market include Early Sense (US), EMFIT (Finland), Eight Sleep (US), Smart Caregiver Corporation (US), Wellsense (US), Tekscan (US), Lenovo Group (Hong Kong) and Sleep Number Corporation (US).
- Published: June 2019
- Price: $ 4950
- TOC Available:
BRIC Diagnostic Imaging Equipment Market by Modality ((X-Ray Imaging (Digital, Analog), MRI (High & Low Field), CT (Conventional, CBCT), Nuclear Imaging (SPECT, Hybrid PET)), End User (Hospitals, Imaging Centers) - Global Forecast to 2024

The BRIC diagnostic imaging equipment market is projected to reach USD 8.3 billion by 2024 from USD 5.3 billion in 2019, at a CAGR of 9.2% during the forecast period. The major factors driving the growth of the BRIC diagnostic imaging equipment market include the rising burden of target diseases and increasing investments, funds, and grants for the modernization of imaging facilities. The major players in the market include GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Carestream Health, Inc. (US), Hologic, Inc. (US), Hitachi, Ltd. (Japan), Allengers (India), CURA Healthcare (India), Neusoft Corporation (China), NP JSC Amico (Russia), SONTU Medical Imaging Equipment Co., Ltd. (China), FUJIFILM Holdings Corporation (Japan), and United Imaging Healthcare Co, Ltd. (China), among others.
- Published: May 2019
- Price: $ 4950
- TOC Available:
Microfluidic Components Market by Product (Valve, Solenoid Valve, Check Valve, Nozzle, Tubing, Micropump, Microneedle, Shuttle Valve), Industry (Automotive, Aerospace & Defense, Healthcare, Consumer Electronics, Oil & Gas) - Global Forecast to 2024

The global microfluidic components market is expected to grow from USD 3.3 billion in 2019 to USD 6.1 billion by 2024, at a compound annual growth rate (CAGR) of 12.7%. during the forecast period.The prominent players in the microfluidic components market are Parker Hannifin Corporation (US), IDEX Corporation (US), Fluigent SA (France), Staiger GmbH & Co. KG (Germany), SMC Corporation (Japan), Camozzi Automation Spa Società Unipersonale (Italy), Aignep s.p.a. (Italy), FIM Valvole Srl (Italy), Humphrey Products Corporation (US), The Lee Company (US), Dolomite Microfluidics (UK), Cellix Ltd. (Ireland), Elveflow (France), and Christian Bürkert GmbH & Co. KG (Germany).
- Published: May 2019
- Price: $ 4950
- TOC Available:
Surgical Tourniquets Market by Type (Tourniquets Systems, Tourniquet Cuffs, Tourniquets Accessories), Applications, End User (Hospitals and Trauma Centers, Ambulatory Surgery Centers, Military) & Region - Global Forecasts to 2024

The surgical tourniquets market is projected to reach USD 509 million by 2024, growing at a CAGR of 8.0%. The increasing incidence of road accidents and falls has resulted in driving the demand for surgical tourniquets. Moreover, rising aging population, and the growing number of joint replacement surgeries are the major factors responsible for the growth of this market. Emerging markets such as China, India, and Japan are the key areas of opportunity for players in this market. However, a dearth of trained professionals will limit market growth to a certain extent. Prominent players in the surgical tourniquets market are Stryker Corporation (US), Zimmer Biomet (US), ulrich medical (Germany), Hammarplast Medical (Sweden), Delfi Medical Innovations (Canada), VBM Medizintechnik (Germany), Pyng Medical (Canada), Zhangjiagang Huaxin Medical Equipment Factory (China), OHK Medical Devices (Israel), Daesung Maref (Korea), Hangzhou Zhengda Medical Co. (China), Dessillons & Dutrillaux (France), and AneticAid (UK).
- Published: May 2019
- Price: $ 4950
- TOC Available:
Veterinary Rapid Test Market by Product (Rapid Test Kit, Rapid Test Readers), Application (Viral, Bacterial, Parasite, Allergies), and Animal Type (Companion (Cat, Dog, Horse), Livestock (Cattle, Swine, Poultry)) - Global Forecast to 2024

The global veterinary rapid tests market is projected to reach USD 854 million by 2024 from USD 573 million in 2019, at a CAGR of 8.3%. Factors contributing to the growth of this market include the increasing prevalence of zoonotic diseases among companion and livestock animals and the growing need for the rapid detection of these diseases. The prominent players in this market are Zoetis, Inc. (US), IDEXX Laboratories, Inc. (US), Heska Corporation (US), Biopanda Reagents Ltd. (UK), Fassisi GmbH (Germany), Virbac (France), BioNote, Inc. (South Korea), SWISSAVANS AG (Switzerland), MEGACOR Diagnostik GmbH (Austria), and Woodley Equipment Company (UK).
- Published: May 2019
- Price: $ 4950
- TOC Available:
Fractional Flow Reserve Market by Technology (Invasive Monitoring, Non-invasive Monitoring), Invasive Monitoring Product (Pressure Guidewires, FFR Measurement Systems), Application, and Region - Global Forecasts to 2024

The fractional flow reserve market is projected to reach USD 1,082 million by 2024, at a CAGR of 16.0%. Growth in this market is primarily attributed to the rising geriatric population and the subsequent growth in the prevalence of cardiovascular diseases, cost benefits of FFR, and the presence of a favorable reimbursement scenario for FFR. The key players in the fractional flow reserve market are Abbott (US), Boston Scientific (US), ACIST Medical Systems (US), Koninklijke Philips N.V. (Netherlands), Opsens, Inc. (Canada), HeartFlow, Inc. (US), Siemens Healthineers (Germany), Pie Medical Imaging (Netherlands), CathWorks (Israel), and Medis Medical Imaging Systems BV (Netherlands).
- Published: April 2019
- Price: $ 4950
- TOC Available:
Central Fill Pharmacy Automation Market by Product (Equipment (Medication Dispensing System, Automated Medication Compounding Systems, Workflow Management), Service (Process Optimization, Facility Design), Software), Vendor - Global Forecast to 2024

The central fill pharmacy automation market is projected to reach USD 656 million by 2024 from USD 381 million in 2019, at a CAGR of 11.5%. The increasing demand for specialty drugs being dispensed by central fill pharmacies is one of the primary drivers propelling the growth of this market.ARxIUM, Inc. (US), RxSafe, LLC (US), TCGRX Pharmacy Workflow Solutions (US), Omnicell, Inc. (US), McKesson Corporation (US), ScriptPro (US), Kuka AG (Germany), Innovation (US), R/X Automation Solutions (US), Tension Packaging & Automation (US), Cornerstone Automation Systems, LLC (CASI, US), and QMSI (US).
- Published: April 2019
- Price: $ 4950
- TOC Available:
Cardiac Resynchronization Therapy Market by Product Type (Cardiac Resynchronization Therapy Defibrillator and Cardiac Resynchronization Therapy Pacemaker), End User (Hospitals & Cardiac Centers and Ambulatory Surgery Centers) & Region - Global Forecasts to 2024

The cardiac resynchronization therapy market is projected to reach USD 5.1 billion by 2024, at a CAGR of 4.4%. The growth of the Cardiac Resynchronization Therapy Market is majorly driven by the increasing incidence of target diseases (primarily due to the rising geriatric population). Rising investments and support, along with technological advancements, are also contributing to the growth of this market. Prominent players in the Cardiac Resynchronization Therapy Market are Medtronic (Ireland), Abbott (US), Boston Scientific Corporation (US), MicroPort Scientific Corporation (China), BIOTRONIK (Germany), and Medico S.p.A. (Italy).
- Published: April 2019
- Price: $ 4950
- TOC Available:
Elastography Imaging Market by Modality (Ultrasound, Magnetic Resonance Elastography), Application (Radiology, Cardiology, OB/GYN, Vascular, Orthopedic and Musculoskeletal), End User (Hospital, Surgery Center, Diagnostic Center) - Global Forecast to 2024

The Elastography Imaging Market is projected to reach USD 4.6 billion by 2024, growing at a CAGR of 11.0 %. The growth of this market is mainly driven by the growing incidence of breast cancer and chronic liver diseases and a rising preference for minimally invasive procedures across the globe. However, the high cost of elastography imaging systems and an unfavorable reimbursement scenario are expected to restrain the growth of this market to a certain extent.
- Published: April 2019
- Price: $ 4950
- TOC Available:
Inflation Device Market by Display Type (Analog & Digital), Capacity (20ml, 30ml, 60ml), Application (Interventional Cardiology, Radiology, Peripheral Vascular, Urology), End User (Hospitals & Clinics, Ambulatory Surgery Centers) - Forecasts to 2024

The inflation device market is projected to reach USD 600 Million by 2024, at a CAGR of 4.7%. The rising adoption of minimally invasive procedures, the presence of developed healthcare infrastructure in a majority of developed countries, the growing incidence of CVD, and the less-stringent approval procedures are contributing to the growth of the market. With the growth of the geriatric population, the prevalence of coronary artery disease is also expected to increase, which is a major target indication for interventional cardiology procedures that utilizes inflation devices to inflate and deflate the balloon. Aforementioned key factors are likely to fuel growth of inflation devices market over the forecast period. The major players operating in the inflation devices market are Merit Medical Systems (US), Boston Scientific Corporation (US), Cardinal Health (US), CONMED Corporation (US), Medtronic plc (Ireland), Acclarent Inc. (US), Cook Medical (US), Atrion Corporation (US), Becton, Dickinson and Company (US), Terumo Medical Corporation (Japan), B. Braun Melsungen AG (US), Olympus Corporation (Japan), Teleflex Incorporated (US), and US Endovascular (US), among others.
- Published: April 2019
- Price: $ 4950
- TOC Available:
Over The Counter/OTC Test Market by Product (Glucose Monitoring Test, Cholesterol Monitoring Test, Infectious Disease Testing, Fecal Occult Test, Urine Analysis Test, Drug Abuse Test), Technology (Immunoassay, Lateral Flow Assay)-Global Forecast to 2024

The Over The Counter Test Market is projected to reach USD 22.2 billion by 2024, at CAGR of 11.0%. The growth of the OTC tests market is mainly driven by the rising prevalence of target diseases and disorders, such as diabetes and infectious diseases, both prominent ailments across the globe that require rapid and effective testing.OraSure Technologies (US), Roche Diagnostics (Switzerland), and i-Health Lab (US).
- Published: April 2019
- Price: $ 4950
- TOC Available:
Medical Equipment Cooling Market by Type (Liquid & Air-based Cooling), Compressor (Scroll, Screw, Centrifugal, Reciprocating), Configuration (Packaged, Modular, Split), Application (MRI, CT, PET, LINAC, Medical Lasers), End User (OEMS, Hospitals & Labs, Diagnostic Treatment Centers & Laboratories) - Global Forecast to 2024

The medical equipment cooling market is projected to grow from an estimated USD 233 million in 2024 to USD 193 million by 2019, at a CAGR of 3.8% during the forecast period. Market growth of the medical equipment cooling market is mainly driven by the economic benefits offered by cooling systems, rising incidence of cancer and other diseases, and growing geriatric population. The global medical equipment cooling market is projected to reach USD 233 million by 2024 from USD 193 million in 2019, at a CAGR of 3.8%.
- Published: March 2019
- Price: $ 4950
- TOC Available:
Medical Vacuum System Market by Product (Standalone, Centralized, Portable), Technology (Dry Claw, Oil Sealed Rotary Vane, Liquid Ring), Application (Diagnostic, Wound Care, GYN), End user (Pharmaceutical, Diagnostic Labs) - Global Forecast to 2024

The Medical Vacuum System Market is estimated to grow at a CAGR of 6.3% to reach USD 1.6 billion by 2024 from USD 1.1 billion in 2018. Some of the major players operating in the market are Atlas Copco AB (Sweden), Gardner Denver Holdings (US), Busch Holding GmbH (Germany), Drägerwerk AG & Co. KGaA (Germany), Asahi Kasei ZOLL Medical Corporation (Japan), Olympus Corporation (Japan), ConvaTec (UK), INTEGRA Holdings (US), Allied Healthcare Products Inc. (US), Medela AG (Switzerland), Air Techniques (US), Laerdal Medical (Norway), Precision Medical, Inc. (US), Medicop (Slovenia), and Ohio Medical Corporation (US) are some major players in the global medical vacuum systems market.
- Published: March 2019
- Price: $ 4950
- TOC Available:
Ligation Devices Market by Product (Hand-held Instruments, Accessories), Procedure (Minimally Invasive & Open Surgery), Application (Gynaecology, GIT, Cardiothoracic, Urology), End User (Hospital, Nursing Homes) - Global Forecast to 2024

The ligation devices market is projected to reach USD 1,189 million by 2024 from USD 876 million in 2019, at a CAGR of 6.3% during the forecast period. Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially minimally invasive surgery (MIS). However, the high cost of ligation devices is a major restraint for this market, particularly in emerging countries. Some of the major players in this market include Ethicon (Johnson and Johnson) (US), Teleflex Incorporated (US), Olympus (Japan), Applied Medical (US), ConMed (US), Cooper Surgical (US), Genicon (US), Grena Think Medical (UK), B.Braun (Germany), and Medtronic (Ireland).
- Published: February 2019
- Price: $ 4950
- TOC Available:
Specimen Retrieval Market by Bag Size (5, 10, 15, 25 mm), Type (Detachable, Non-detachable), Application (Gynecology, Urology, Gastrointestinal Surgery), End User (Hospitals, Ambulatory Surgical Centers, Nursing Home) & Region - Global Forecasts to 2024

The specimen retrieval market is projected to reach USD 290 million by 2024, at a CAGR of 4.7%. Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially laparoscopic surgeries. However, the high cost of specimen retrieval systems is a major challenge for this market, particularly in emerging countries. Some of the major players in this market include Johnson & Johnson Services, Inc. (US), Teleflex Incorporated (US), Applied Medical Resources Corporation (US), CONMED Corporation (US), Cooper Surgical, Inc. (US), Genicon (US), B. Braun Melsungen AG (Germany), Laprosurge (UK), Purple Surgical (UK), and Medtronic (Ireland).
- Published: February 2019
- Price: $ 4950
- TOC Available:
Dental Biomaterials Market by Type (Metallic (Titanium, Stainless Steel, Chromium Alloy, Amalgam, Gold), PFM, Ceramic, Bone Graft, Polymer Biomaterials), Application (Implantology, Prosthetic, Orthodontic), End User & Region - Global Forecasts to 2023

The dental biomaterials market is projected to reach USD 9.6 billion by 2023, at a CAGR of 7.4%. The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth. The prominent players in the dental biomaterials market include Institut Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, Inc. (US), Mitsui Chemicals ,Inc. (Japan), Victrex Plc (UK), Ivoclar Vivadent AG (Principality of Liechtenstein), GC Corporation (Japan), Keystone Dental, Inc. (US), Datum Dental Ltd (Israel), BEGO Medical GmbH (Germany), and Cam Bioceramics B.V (Netherland).
- Published: January 2019
- Price: $ 4950
- TOC Available:
Hemostasis Valve Market by Type (Hemostasis Valve Y Connector, Double Y Connector Hemostasis Valve, One Handed), Application (Angioplasty, Angiography), End User (Hospitals), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023

The hemostasis valves market is projected to grow from USD 132 million in 2018 to USD 175 million by 2023, at a CAGR of 5.8% during the forecast period. Growth in the hemostasis valves market is mainly driven by the increasing number of interventional procedures. Merit Medical Systems (US), Abbott (US), Teleflex Incorporated (US), Boston Scientific (US), B. Braun Melsungen (Germany), DeRoyal Industries, Inc. (US), Freudenberg Medical (US), Scitech (Brazil), and Argon Medical (US).
- Published: January 2019
- Price: $ 4950
- TOC Available:
Neonatal Care Equipment and Fetal (Labor & Delivery) Market - (Ultrasound, Doppler, Fetal Monitors (Intrapartum, Antepartum), Warmer, Incubator, Pulse Oximeter, Phototherapy Devices, Ventilator, MRI, CPAP, Capnograph, Resuscitator)-Global Forecast to 2023

The fetal and neonatal care equipment market is projected to grow USD 8.4 billion by 2023, at a CAGR of 5.7% during the forecast period. Growth in the fetal and neonatal care equipment market is mainly driven by the rise in number of preterm and low-weights birth infants, growing number of NICU admissions, and increased awareness of neonatal and fetal care across developing nations.GE Healthcare (U.K.), Philips Healthcare (Netherlands), Drägerwerk AG & Co. KGaA (Germany), Medtronic plc (Ireland), and Masimo Corporation (U.S.).
- Published: December 2018
- Price: $ 4950
- TOC Available:
Surgical Snare Market by Usability (Singel Use, Reusable), Application (GI Endoscopy, Laparoscopy, Urology Endoscopy, Gynecology Endoscopy, Arthroscopy, Bronchoscopy, Mediastinoscopy, Laryngoscopy), End User (Hospital, ASC) & Region - Global Forecasts to 2023

The surgical snare Market is projected to USD 1,255 million by 2023, at a CAGR of 4.8%. The major driving factors in the surgical snares market are increasing number for colon polypectomy procedures, growth of the endoscopic ambulatory surgical centers, and a rising preference for minimally invasive surgeries are the key factors. The major surgical snares providers include Olympus (Japan), Boston Scientific (US), Cook Medical (US), CONMED Corporation (US), Medline Industries (US), Medtronic (Ireland), Steris (US), Merit Medical Systems (US), and Avalign Technologies (US).
- Published: November 2018
- Price: $ 4950
- TOC Available:
Veterinary X-ray Market by Technology (Direct, Computed, Film), Type (Digital, Analog), Mobility (Fixed, Portable), Animal (Companion, Large Animal), Application (Trauma, Oncology, Dental), End User (Clinic, Hospital) - Forecasts to 2023

The veterinary X-ray market is projected to reach USD 872 million by 2023, at a CAGR of 6.4%. Rising animal health expenditure and growing demand for pet insurance, increasing number of veterinary practitioners in developed regions, and growth in the companion animals market are the primary drivers for the veterinary X-ray market during the forecast period. The prominent players in the veterinary X-ray market are IDEXX (US), Fujifilm (Japan), Onex Corporation (Canada), Sedecal (Spain), Agfa-Gevaert (Belgium), Sound Technologies (US), Fujifilm Holdings Corporation (Japan), Canon, Inc (Japan), Examion (Germany), Konica Minolta (US), DRE Veterinary (US), and Heska Corporation (US).
- Published: November 2018
- Price: $ 4950
- TOC Available:
Pacemakers Market by Implantability (External), Technology (Single Chamber, Dual Chamber, CRT-P/Biventricular Pacemaker), Type (Conventional, MRI Compatible), End User (Hospitals and Cardiac Centers, Ambulatory Surgical Center) - Global Forecasts to 2023

The pacemakers market is projected to reach USD 4.9 billion by 2023, at a CAGR of 2.0%. Growth in this market is driven by increasing prevalence of cardiovascular diseases and technological advancements in devices. Major vendors in the pacemakers market include Medtronic (Ireland), Abbott (US), and Boston Scientific (US), BIOTRONIK (Germany), LivaNova (UK), OSCOR (US), Pacetronix (India), MEDICO (Italy), Osypka Medical (Germany), and Lepu Medical (China).
- Published: November 2018
- Price: $ 4950
- TOC Available: